A&J Science is based in South Korea, dedicated to the discovery and development of drugs targeting intractable infections. With cutting-edge technology of a proprietary, fully synthetic platform, we pioneer innovative solutions by leveraging novel natural products to combat antimicrobial resistance (AMR) threats. We develop novel thiopeptides as antibiotics for difficult to treat chronic infectious diseases, including those caused by C. difficile (AJ-024), as well as non-tuberculous mycobacteria and Pseudomonas (AJ-099). We are looking to establish partnerships with Pharma and Biotech.